-
Your selected country is
Singapore
- Change country/language
-
Reagents
- Flow Cytometry Reagents
-
Western Blotting and Molecular Reagents
- Immunoassay Reagents
-
Single-Cell Multiomics Reagents
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ TCR/BCR Profiling Assays for Human and Mouse
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
-
Functional Assays
-
Microscopy and Imaging Reagents
-
Cell Preparation and Separation Reagents
-
Training
- Flow Cytometry Basic Training
-
Product-Based Training
- FACSAria Product Based Training
- FACSMelody Product-Based Training
- FACSLyric Product-Based Training
- FACSCanto Product-Based Training
- LSRFortessa Product-Based Training
- FACSymphony Product-Based Training
- FACSDuet Product-Based Training
- HTS Product-Based Training
- BD FACSDiscover™ S8 Cell Sorter Product Training
-
Advanced Training
-
Thought Leadership
-
Product News
- Blogs
- Scientific Publications
-
Events
- Nature Research Academies Workshop 2023
- CYTO 2023: Advancing the World of Cytometry
- Singapore Gene & Cell Therapy Conference 2023
- EuroFlow Educational Workshop
- Nature Research Masterclass 2023
- Novel Approaches to Single-Cell Plant Research: from Real-Time Imaging Cell Sorting to Single-Nuclei Transcriptomics
- Advances in Immune Monitoring Series
-
Product News
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ TCR/BCR Profiling Assays for Human and Mouse
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
-
- FACSAria Product Based Training
- FACSMelody Product-Based Training
- FACSLyric Product-Based Training
- FACSCanto Product-Based Training
- LSRFortessa Product-Based Training
- FACSymphony Product-Based Training
- FACSDuet Product-Based Training
- HTS Product-Based Training
- BD FACSDiscover™ S8 Cell Sorter Product Training
-
- Nature Research Academies Workshop 2023
- CYTO 2023: Advancing the World of Cytometry
- Singapore Gene & Cell Therapy Conference 2023
- EuroFlow Educational Workshop
- Nature Research Masterclass 2023
- Novel Approaches to Single-Cell Plant Research: from Real-Time Imaging Cell Sorting to Single-Nuclei Transcriptomics
- Advances in Immune Monitoring Series
- Singapore (English)
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
The Complex Interplay of Immune Dysfunction in
B-Cell Malignancies
The spectrum of secondary immunodeficiency (SID) associated with B-cell lymphoproliferative diseases (B-CLPD) encompasses defects primarily in antibody production and hypogammaglobulinemia, alongside varying T cell and innate immunity defects. Like primary immunodeficiency disorders (PID), a classification system is warranted to categorize SID defects and assess infection risk.
Despite similarities in infection profiles between PID and SID to B-CLPD, it is of utmost importance to rule out PID at B-CLPD diagnosis, which has clinical and prognostic implications for the patients and their families. An integrated approach that incorporates immunological biomarkers alongside traditional prognostic indicators is essential for enhancing diagnostic accuracy and tailoring risk-adapted therapies in patients with B-CLPD and concurrent immune dysfunction. Collaboration between hematologists and immunologists is imperative for navigating the complex landscape of immune dysfunction in cancer.
Join us to learn:
- The clinical relevance of an adequate assessment and classification of the immunodeficiency in B-CLPD in predicting disease progression and guiding treatment decisions.
- The challenges in diagnosing primary versus secondary immunodeficiency and the importance of early recognition.
- Through exploration of the genomic landscape of B-CLPD and its intersection with PID, potential shared pathways and therapeutic targets are underscored, highlighting the relevance of interdisciplinary collaboration and integrated approaches to patient care.
Speakers
Silvia Sánchez-Ramón, MD, Ph.D.
Head Immunology Department, Hospital Clínico San Carlos, Madrid
Associate Professor, Complutense University of Madrid
Silvia Sánchez Ramón is the Head of the Immunology Department at the Hospital Clínico San Carlos, and an associate professor at the Faculty of Medicine of the Universidad Complutense de Madrid. She works as a clinical immunologist and researcher in the field of primary and secondary immunodeficiencies and immunoregulation.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.